Abstract 2498: Proteomic analysis reveals Src/Stat and EGFR/MAPK pathways as potential mechanism of resistance to PI3K inhibitors in lung cancer

MLA

Maria Angelica Cortez, et al. “Abstract 2498: Proteomic Analysis Reveals Src/Stat and EGFR/MAPK Pathways as Potential Mechanism of Resistance to PI3K Inhibitors in Lung Cancer.” Cancer Research, vol. 73, Apr. 2013, p. 2498. EBSCOhost, https://doi.org/10.1158/1538-7445.am2013-2498.

APA

Maria Angelica Cortez, Lauren Averett Byers, Hai T. Tran, Philip Groth, John D. Minna, John V. Heymach, Lixia Diao, Jayanthi Gudikote, You Hong Fan, Liu Ningshu, Julianne Paul, Kevin R. Coombes, Uma Giri, & Jing Wang. (2013). Abstract 2498: Proteomic analysis reveals Src/Stat and EGFR/MAPK pathways as potential mechanism of resistance to PI3K inhibitors in lung cancer. Cancer Research, 73, 2498. https://doi.org/10.1158/1538-7445.am2013-2498

Chicago

Maria Angelica Cortez, Lauren Averett Byers, Hai T. Tran, Philip Groth, John D. Minna, John V. Heymach, Lixia Diao, et al. 2013. “Abstract 2498: Proteomic Analysis Reveals Src/Stat and EGFR/MAPK Pathways as Potential Mechanism of Resistance to PI3K Inhibitors in Lung Cancer.” Cancer Research 73 (April): 2498. doi:10.1158/1538-7445.am2013-2498.